Evaluation of antioxidant systems in pituitary-adrenal axis diseases

Pituitary

Volumn 13, Issue 2, 2010, Pages 138-145

  Mancini, A ^a   Leone, E ^a   Silvestrini, A ^a   Festa, R ^b   Di Donna, V ^a   De Marinis, L ^a   Pontecorvi, A ^a   Littarru, G P ^b   Meucci, E ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Adrenal gland; Antioxidants; Coenzyme Q10; Cortisol; Pituitary; Total antioxidant capacity

Indexed keywords

2,2' AZINOBIS(3 ETHYLBENZOTHIAZOLINE 6 SULFONIC ACID); METMYOGLOBIN; THYROID HORMONE; UBIDECARENONE; ANTIOXIDANT; UBIQUINONE;

ADRENAL DISEASE; ADRENAL HYPERPLASIA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOPHYSIS DISEASE; HYPOTHYROIDISM; MALE; PRIORITY JOURNAL; SPECTROSCOPY; THYROID HORMONE METABOLISM; ADRENAL INSUFFICIENCY; CONGENITAL ADRENAL HYPERPLASIA; METABOLISM; PATHOLOGY;

ADRENAL HYPERPLASIA, CONGENITAL; ADRENAL INSUFFICIENCY; ANTIOXIDANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; HYPOTHYROIDISM; PITUITARY-ADRENAL SYSTEM; UBIQUINONE;

EID: 77955346271     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-009-0213-z     Document Type: Article

References (48)

1. Baxter JD, Forsham PH (1972) Tissue effects of glucocorticoids. Am J Med 53:573-589
2. Krieger DT (1975) Rhythms of ACTH and corticosteroid secretion in health and disease, and their experimental modification. J Steroid Biochem 6:785-791
3. Howlett TA, Rees LH, Besser GM (1985) Cushing's syndrome. Clin Endocrinol Metab 14:911-945
4. Burke CW (1985) Adrenocortical insufficiency. Clin Endocrinol Metab 14:947-976
5. Chrousos GP, Gold PW (1998) A healthy body in a healthy mindand viceversa-the damaging power of "uncontrollable" stress. J Clin Endocrinol Metab 83:1842-1845
6. Rosmond R, Bjorntorp P (2000) The hypothalamic-pituitaryadrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Inter Med 247:188-197
7. Colao A, Pivonello R, Spiezia S et al (1999) Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 84:2664-2672
8. Erichsen MM, Lovas K, Fougner KJ et al (2009) Normal overall mortality rate in Addison's diseases, but young patients are at risk of premature death. Eur J Endocrinol 160:233-237
9. Giordano R, Marzotti S, Balbo M, et al. (2009) Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement. J Endocrinol Invest Jul 20 [Epub ahead of print]. doi:10.3275/6437
10. Lakka HM, Laaksonen DE, Lakka TA et al (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-2716
11. Isomaa B, Almgren P, Tuomi T et al (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-689
12. Orchard TJ, Virella G, Forrest KY et al (1999) Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburg epidemiology of diabetes complications study. Diabetes 48:1454-1458
13. Laight DW, Desai KM, Gopaul NK et al (1999) F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamine E. Eur J Pharmacol 377:89-92
14. Kodama M, Inoue F, Saito H, Oda T, Sato Y (1997) Formation of free radicals from steroid hormones: possible significance in environmental carcinogenesis. Anticancer Res 17:439-444
15. Hornsby PJ (1986) Cytochrome P-450/pseudosubstrate interactions and the role of antioxidants in the adrenal cortex. Endocr Res 12:469-494
16. Dandona P, Suri M, Hamouda W et al (1999) Hydrocortisoneinduced inhibition of reactive oxygen species by polymorphonuclear neutrophils. Crit Care Med 27:2583-2584
17. Bekesi G, Kakucs R, Varbiro S et al (2000) In vitro effects of different steroid hormones on superoxide anion production of human neutrophil granulocytes. Steroids 65:889-894
18. Morin C, Zini R, Simon N et al (2000) Low glucocorticoid concentrations decrease oxidative phosphorylation of isolated rat brain mitochondria: an additional effect of desamethasone. Fundam Clin Pharmacol 14:493-500
19. Mc Anulty SR, Mc Anulty LS, Nieman DC et al (2003) Influence of carbohydrate ingestion on oxidative stress and plasma antioxidant potential following a 3 h run. Free Rad Res 37:835-840
20. Zelinskii BA, Vlasenko MV (1990) Lipid peroxidation in patients with chronic adrenal cortex failure. Probl Endokrinol 36:37-40
21. Prazny M, Jezkova J, Horova E et al (2008) Impaired microvascular reactivity and endothelial function in patients with Cushing's syndrome: influence of arterial hypertension. Physiol Res 57:13-22
22. Tishenina RS (1986) a-tocopherol concentration of the blood plasma and erythrocytes in patients with symptomatic obesity due to hypothalamo- hypophyseal-adrenal disease. Probl Endokrinol (Mosk) 32:25-30
23. Keen JA, McLaren M, Chandler KJ, McGorum BC (2004) Biochemical indices of vascular function, glucose metabolism and oxidative stress in horses with equine Cushing's disease. Equine Vet J 36:226-229
24. Mancini A, De Marinis L, Calabrò F et al (1991) Physiopathological relevance of Coenzyme Q10 in thyroid disorders: CoQ10 concentrations in normal and diseased human thyroid tissue. In: Folkers K, Littarru GP, Yamagami T (eds) Biomedical and clinical aspects of coenzyme Q. Elsevier, Amsterdam, pp 441-448
25. Mancini A, Calabrò F, Fiumara C et al (1992) Plasma Coenzyme Q10 determination in acromegaly. Exp Clin Endocrinol Life Sci Adv 11:55-60
26. Dokmetas HS, Colak R, Kelestimur F, Selcuklu A, Unluhizarci K, Bayram F (2000) A comparison between the 1-mg adrenocorticotropin (ACTH) test, the short ACTH (250 lg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitaryadrenal axis immediately after pituitary surgery. J Clin Endocrinol Metab 85:3713-3719
27. Mosca F, Fattorini D, Bompadre S et al (2002) Assay of Coenzyme Q(10) in plasma by a single dilution step. Anal Biochem 305:49-52
28. Tomasetti M, Alleva R, Solenghi MD et al (1999) Distribution of antioxidants among blood components and lipoproteins: significance of lipids/CoQ10 ratio as a possible marker of increased risk for atherosclerosis. Biofactors 9:231-240
29. Meucci E, Milardi D, Mordente A et al (2003) Total antioxidant capacity in patients with varicoceles. Fertil Steril 79:1577-1583
30. Rice-Evans C, Miller NJ (1994) Total antioxidant status in plasma and body fluids. Methods Enzymol 234:279-293
31. Thomas ST, Leichtweis SB, Pettersson K et al (2001) Dietary cosupplementation with vitamin E and CoQ10 inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol 21:585-593
32. Singh RB, Neki NS, Kartikey K et al (2003) Effect of Coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction. Mol Cell Biochem 246:75-82
33. Yalcin A, Kilinc E, Sagcan A et al (2004) Coenzyme Q10 concentrations in coronary artery disease. Clin Biochem 37: 706-709
34. Koroshetz WJ, Jenkins BG, Rosen BR et al (1997) Assessment of energy metabolism defects in Huntington's disease and possible therapy with coenzyme Q10. Ann Neurol 41:160-165
35. Beal MF, Matthews RT (1997) Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases. Mol Aspects Med 18:169-179
36. Crane FL (2001) Biochemical functions of coenzyme Q10. J Am Coll Nutr 20:591-598
37. Groneberg DA, Kindermann S, Althammer M et al (2001) Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCO-2 cells. Int J Biochem Cell Biol 37:1208-1218
38. Prior RL, Cao G (1999) In vivo total antioxidant capacity: comparison of different analytical methods. Free Rad Biol Med 27:1173-1181
39. Bartoz G (2003) Total antioxidant capacity. Adv Clin Chem 37:219-292
40. Chevion S, Chevion M (2000) Antioxidant status and human health. Use of cyclic voltammetry for the evaluation of the antioxidant capacity of plasma and of edible plants. Ann N Y Acad Sci 899:308-325
41. Kedziora-Kornatowska K, Bartosz M, Mussur M et al (2003) The total antioxidant capacity of blood plasma during cardiovasculary bypass surgery in patients with coronary heart disease. Cell Mol Biol Lett 8:973-977
42. Dorin RI, Qualls CR, Crapo LM (2003) Diagnosis of adrenal insufficiency. Ann Intern Med 139:194-204
43. Reimondo G, Bovio S, Allasino B, Terzolo M, Angeli A (2008) Secondary hypoadrenalism. Pituitary 11:147-154
44. Mancini A, Leone E, Festa R et al (2008) Effects of testosterone on antioxidant systems in male secondary hypogonadism. J Androl 29:622-629
45. Tsopanakis C, Tsopanakis A (1998) Stress hormonal factors, fatigue, and oxidant responses to prolonged speed driving. Pharmacol Biochem Behav 60:747-751
46. Vargas CR, Wajner M, Sirtori LR et al (2004) Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy. Biochim Biophys Acta 20:26-32
47. Di Biase A, Salvati S, Vari R et al (2000) Susceptibility to oxidation of plasma low-density lipoprotein in X-linked adrenoleukodystrophy: effects of simvastatin treatment. Mol Genet Metab 71:651-655
48. Baschetti R (2003) Chronic fatigue syndrome: an endocrine disease off limits for endocrinologists? Eur J Clin Invest 33: 1029-1031